AVITA Medical Total Assets 2011-2026 | RCEL

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets AVITA Medical

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
56.4 M	79.7 M	112 M	98.3 M	116 M	82.5 M	25.7 M	16.9 M	5.89 M	6.42 M	4.17 M	6.89 M	11.8 M	11 M	18.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
116 M	4.17 M	43.5 M

Quarterly Total Assets AVITA Medical

2025-Q3	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
63.7 M	69.6 M	79.7 M	81.1 M	87.8 M	97.4 M	112 M	81 M	86.3 M	92.6 M	98.3 M	99.9 M	103 M	106 M	116 M	121 M	126 M	126 M	69.3 M	75.4 M	82.5 M	82.5 M	-	-	25.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
126 M	25.8 M	90.5 M

Total Assets of other stocks in the Medical devices industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	110 M	-	-	$ 475 M	USA
GenMark Diagnostics, Inc. GNMK	224 M	-	-	$ 1.77 B	USA
Axonics Modulation Technologies AXNX	659 M	-	-	$ 3.31 B	USA
Acutus Medical AFIB	54 M	-	-26.83 %	$ 2.62 M	USA
Obalon Therapeutics, Inc. OBLN	10.6 M	-	-5.86 %	$ 30.6 M	USA
Aziyo Biologics AZYO	43.4 M	-	1.37 %	$ 20.5 M	USA
Apyx Medical Corporation APYX	79.2 M	$ 3.88	-1.02 %	$ 134 M	USA
Cognyte Software Ltd. CGNT	498 M	$ 6.9	-4.17 %	$ 495 M	Israel
Alphatec Holdings ATEC	776 M	$ 13.17	-2.23 %	$ 1.88 B	USA
BIOLASE BIOL	35.1 M	-	-13.19 %	$ 166 K	USA
Bio-Rad Laboratories BIO	9.36 B	$ 292.08	-0.55 %	$ 8.24 B	USA
Conformis CFMS	94 M	-	-	$ 16.4 M	USA
Bruker Corporation BRKR	5.81 B	$ 36.61	-13.72 %	$ 5.46 K	USA
BioSig Technologies BSGM	842 K	-	37.08 %	$ 85.7 M	USA
CONMED Corporation CNMD	2.31 B	$ 41.57	-1.8 %	$ 1.28 B	USA
Boston Scientific Corporation BSX	39.4 B	$ 74.23	1.03 %	$ 109 B	USA
Abbott Laboratories ABT	81.4 B	$ 112.24	-1.19 %	$ 195 B	USA
Cardiovascular Systems CSII	323 M	-	0.15 %	$ 844 M	USA
Cutera CUTR	346 M	-	-10.19 %	$ 1.99 M	USA
CryoLife, Inc. CRY	789 M	-	-4.14 %	$ 702 M	USA
ClearPoint Neuro CLPT	39.2 M	$ 13.0	-2.8 %	$ 351 M	USA
EDAP TMS S.A. EDAP	86.1 M	$ 4.82	-1.73 %	$ 180 M	France
Soliton, Inc. SOLY	33.8 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	10.5 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	64.1 M	-	0.03 %	$ 1.58 B	Israel
Dynatronics Corporation DYNT	15.4 M	-	14.99 %	$ 929 K	USA
Misonix, Inc. MSON	204 M	-	-	$ 462 M	USA
Neovasc NVCN	66.2 M	-	-	$ 111 M	Canada
Electromed ELMD	53.8 M	$ 23.39	-7.4 %	$ 198 M	USA
Intersect ENT, Inc. XENT	227 M	-	-	$ 955 M	USA
Eargo EAR	132 M	-	-	$ 10.2 M	USA
InMode Ltd. INMD	786 M	$ 14.36	0.81 %	$ 1.14 B	Israel
GBS GBS	8.25 M	-	-0.57 %	$ 7.12 M	USA
Second Sight Medical Products EYES	41.6 M	-	-0.97 %	$ 54.4 M	USA
Avinger AVGR	13.8 M	-	-20.74 %	$ 369 K	USA
FONAR Corporation FONR	199 M	$ 18.54	-0.22 %	$ 122 M	USA
Globus Medical GMED	5.25 B	$ 87.0	-1.43 %	$ 11.8 B	USA
IRadimed Corporation IRMD	98.3 M	$ 99.45	-3.52 %	$ 1.26 B	USA
Integer Holdings Corporation ITGR	3.08 B	$ 84.9	-2.62 %	$ 2.85 B	USA
Myomo MYO	10.2 M	$ 0.8	0.29 %	$ 5.64 M	USA
Integra LifeSciences Holdings Corporation IART	4.04 B	$ 10.88	-2.68 %	$ 838 M	USA
Establishment Labs Holdings ESTA	347 M	$ 72.93	0.29 %	$ 2.05 B	Costa-rica
IRIDEX Corporation IRIX	34.4 M	$ 1.35	-5.59 %	$ 21.8 M	USA
Invacare Corporation IVC	771 M	-	-	$ 24.7 M	USA
Cytosorbents Corporation CTSO	47.4 M	$ 0.63	1.76 %	$ 34.3 M	USA
Pulmonx Corporation LUNG	163 M	$ 1.44	-1.03 %	$ 56.3 M	USA
OrthoPediatrics Corp. KIDS	473 M	$ 16.62	-3.48 %	$ 384 M	USA